ClinicalTrials.gov
public full text
Public Domain
Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis
we hypothesize that PTX might be effective in lowering proteinuria by modulating renal MCP-1 production in human glomerulonephritis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pentoxifylline in Diabetic Kidney Disease#387291
- Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy#828986
- Pentoxifylline in Lupus Nephritis#1161729
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy#1138972
- HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria#861294
Record · ID 1128206
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive